These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24777711)

  • 21. Bayesian meta-analysis using SAS PROC BGLIMM.
    Rott KW; Lin L; Hodges JS; Siegel L; Shi A; Chen Y; Chu H
    Res Synth Methods; 2021 Nov; 12(6):692-700. PubMed ID: 34245227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons.
    König J; Krahn U; Binder H
    Stat Med; 2013 Dec; 32(30):5414-29. PubMed ID: 24123165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling time-course relationships with multiple treatments: Model-based network meta-analysis for continuous summary outcomes.
    Pedder H; Dias S; Bennetts M; Boucher M; Welton NJ
    Res Synth Methods; 2019 Jun; 10(2):267-286. PubMed ID: 31013000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence inconsistency degrees of freedom in Bayesian network meta-analysis.
    Lin L
    J Biopharm Stat; 2021 May; 31(3):317-330. PubMed ID: 33296239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A graphical tool for locating inconsistency in network meta-analyses.
    Krahn U; Binder H; König J
    BMC Med Res Methodol; 2013 Mar; 13():35. PubMed ID: 23496991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graphical exploration of network meta-analysis data: the use of multidimensional scaling.
    Chung H; Lumley T
    Clin Trials; 2008; 5(4):301-7. PubMed ID: 18697844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the consistency assumptions underlying network meta-regression using aggregate data.
    Donegan S; Dias S; Welton NJ
    Res Synth Methods; 2019 Jun; 10(2):207-224. PubMed ID: 30367548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network meta-analysis with integrated nested Laplace approximations.
    Sauter R; Held L
    Biom J; 2015 Nov; 57(6):1038-50. PubMed ID: 26360927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of evidence of inconsistency and its association with network structural characteristics in 201 published networks of interventions.
    Veroniki AA; Tsokani S; White IR; Schwarzer G; Rücker G; Mavridis D; Higgins JPT; Salanti G
    BMC Med Res Methodol; 2021 Oct; 21(1):224. PubMed ID: 34689743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evidence-splitting approach to evaluation of direct-indirect evidence inconsistency in network meta-analysis.
    Shih MC; Tu YK
    Res Synth Methods; 2021 Mar; 12(2):226-238. PubMed ID: 33543575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study.
    Song F; Xiong T; Parekh-Bhurke S; Loke YK; Sutton AJ; Eastwood AJ; Holland R; Chen YF; Glenny AM; Deeks JJ; Altman DG
    BMJ; 2011 Aug; 343():d4909. PubMed ID: 21846695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplicative interaction in network meta-analysis.
    Piepho HP; Madden LV; Williams ER
    Stat Med; 2015 Feb; 34(4):582-94. PubMed ID: 25410043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network meta-analysis: application and practice using R software.
    Shim SR; Kim SJ; Lee J; Rücker G
    Epidemiol Health; 2019; 41():e2019013. PubMed ID: 30999733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a protocol for a systematic review and network meta-analysis.
    He S; Zou Y; Li J; Liu J; Zhao L; Yang H; Su Z; Ye H
    BMJ Open; 2020 Feb; 10(2):e033917. PubMed ID: 32047017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostics for generalized linear hierarchical models in network meta-analysis.
    Zhao H; Hodges JS; Carlin BP
    Res Synth Methods; 2017 Sep; 8(3):333-342. PubMed ID: 28683516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons.
    Pechlivanoglou P; Abegaz F; Postma MJ; Wit E
    Pharm Stat; 2015; 14(4):322-31. PubMed ID: 25958984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis.
    Achana FA; Cooper NJ; Dias S; Lu G; Rice SJ; Kendrick D; Sutton AJ
    Stat Med; 2013 Feb; 32(5):752-71. PubMed ID: 22865748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data.
    Seide SE; Jensen K; Kieser M
    Res Synth Methods; 2020 May; 11(3):363-378. PubMed ID: 31955519
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.